Laura Lazzeri
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
T2-Reg: a regional web registry on Th2-mediated diseases.
Journal: Italian journal of dermatology and venereology
Published: January 12, 2026
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: November 07, 2025
Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study.
Journal: Clinical and experimental dermatology
Published: October 21, 2025
Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study.
Journal: Clinical and experimental dermatology
Published: July 01, 2025
Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: May 23, 2025
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study.
Journal: International journal of dermatology
Published: May 21, 2025
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis.
Journal: Clinical and experimental dermatology
Published: April 04, 2025
Belimumab as a potential therapeutic option for bullous systemic lupus erythematosus.
Journal: Italian journal of dermatology and venereology
Published: January 22, 2025
Eyelid Contact Dermatitis: 25-Year Single-Center Retrospective Study.
Journal: Journal of clinical medicine
Published: December 15, 2024
Clinical course of atopic dermatitis after dupilumab discontinuation: a multicentre real-world study.
Journal: Clinical and experimental dermatology
Published: November 19, 2024
Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?
Journal: Journal of personalized medicine
Published: June 16, 2024
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study.
Journal: Journal of clinical medicine
Published: May 30, 2024
Last Updated: 09/26/2026